Liraglutide treatment induced a slight reduction of body weight during the first week of administration in WT and Wfs1 KO animals (Figure 1a), in agreement with our previous work using GLP1 receptor agonists in this rat model of WS [19,20,21]. This evidence concerns the gene WFS1 and Werner syndrome.